BIZ NEWS: Merck to buy cancer drug developer ArQule for $2.7B in cash - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Monday, 9 December 2019

BIZ NEWS: Merck to buy cancer drug developer ArQule for $2.7B in cash


Merck to buy cancer drug developer ArQule for $2.7B in cash



The offer of $20 per share for ArQule is more than double its closing price on Friday.

via FOX BUSINESS NEWS https://ift.tt/36mohXL

No comments:

Post a Comment

Post Top Ad